Search

Despite major advances in artificial intelligence (AI) for medicine and healthcare, the deployment and adoption of AI technologies remain limited in real-world clinical practice. In recent years, concerns have been raised about the technical, clinical, ethical and legal risks associated with medical AI. To increase real world adoption, it is essential that medical AI tools are trusted and accepted by patients, clinicians, health organisations and authorities. This work describes the FUTURE-AI guideline as the first international consensus framework for guiding the development and deployment of trustworthy AI tools in healthcare. The FUTURE-AI consortium was founded in 2021 and currently comprises 118 inter-disciplinary experts from 51 countries representing all continents, including AI scientists, clinicians, ethicists, and social scientists. Over a two-year period, the consortium defined guiding principles and best practices for trustworthy AI through an iterative process comprising an in-depth literature review, a modified Delphi survey, and online consensus meetings. The FUTURE-AI framework was established based on 6 guiding principles for trustworthy AI in healthcare, i.e. Fairness, Universality, Traceability, Usability, Robustness and Explainability. Through consensus, a set of 28 best practices were defined, addressing technical, clinical, legal and socio-ethical dimensions. The recommendations cover the entire lifecycle of medical AI, from design, development and validation to regulation, deployment, and monitoring. FUTURE-AI is a risk-informed, assumption-free guideline which provides a structured approach for constructing medical AI tools that will be trusted, deployed and adopted in real-world practice. Researchers are encouraged to take the recommendations into account in proof-of-concept stages to facilitate future translation towards clinical practice of medical AI.

Effectively determining malaria parasitemia is a critical aspect in assisting clinicians to accurately determine the severity of the disease and provide quality treatment. Microscopy applied to thick smear blood smears is the de facto method for malaria parasitemia determination. However, manual quantification of parasitemia is time consuming, laborious and requires considerable trained expertise which is particularly inadequate in highly endemic and low resourced areas. This study presents an end-to-end approach for localisation and count of malaria parasites and white blood cells (WBCs) which aid in the effective determination of parasitemia; the quantitative content of parasites in the blood. On a dataset of slices of images of thick blood smears, we build models to analyse the obtained digital images. To improve model performance due to the limited size of the dataset, data augmentation was applied. Our preliminary results show that our deep learning approach reliably detects and returns a count of malaria parasites and WBCs with a high precision and recall. We also evaluate our system against human experts and results indicate a strong correlation between our deep learning model counts and the manual expert counts (p=0.998 for parasites, p=0.987 for WBCs). This approach could potentially be applied to support malaria parasitemia determination especially in settings that lack sufficient Microscopists., Comment: 6 pages, 3 figures,2020 NeurIPS ML4D workshop

Point of care diagnostics using microscopy and computer vision methods have been applied to a number of practical problems, and are particularly relevant to low-income, high disease burden areas. However, this is subject to the limitations in sensitivity and specificity of the computer vision methods used. In general, deep learning has recently revolutionised the field of computer vision, in some cases surpassing human performance for other object recognition tasks. In this paper, we evaluate the performance of deep convolutional neural networks on three different microscopy tasks: diagnosis of malaria in thick blood smears, tuberculosis in sputum samples, and intestinal parasite eggs in stool samples. In all cases accuracy is very high and substantially better than an alternative approach more representative of traditional medical imaging techniques., Comment: Presented at 2016 Machine Learning and Healthcare Conference (MLHC 2016), Los Angeles, CA